Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 10:02 am Sale |
2024-12-31 | 13G | Cadiz Inc. CDZI |
272 Capital LP | 1,050,000 1.400% |
-2,472,582 (-70.19%) |
Filing History |
| 2024-11-14 12:31 pm Sale |
2024-09-30 | 13G | Harvard Bioscience, Inc. HBIO |
272 Capital LP | 1,555,820 3.600% |
-1,383,458 (-47.07%) |
Filing History |
| 2024-11-14 12:30 pm Purchase |
2024-09-30 | 13G | Cadiz Inc. CDZI |
272 Capital LP | 3,522,582 5.200% |
3,522,582 (New Position) |
Filing History |
| 2024-02-14 08:48 am Sale |
2023-12-31 | 13G | The Arena Group Holdings, Inc. AREN |
272 Capital LP | 0 0.000% |
-1,654,698 (Position Closed) |
Filing History |
| 2024-02-14 08:46 am Sale |
2023-12-31 | 13G | Harvard Bioscience, Inc. HBIO |
272 Capital LP | 2,939,278 6.900% |
-325,518 (-9.97%) |
Filing History |
| 2023-10-27 4:30 pm Purchase |
2023-04-03 | 13D | Sequans Communications S.A. SQNS |
272 Capital LP | 18,005,506 18.500% |
10,057,286 (+126.54%) |
Filing History |
| 2023-02-16 3:13 pm Unchanged |
2022-12-31 | 13G | The Arena Group Holdings, Inc. AREN |
272 Capital LP | 1,654,698 9.100% |
0 (Unchanged) |
Filing History |
| 2023-02-16 3:11 pm Unchanged |
2022-12-31 | 13G | Harvard Bioscience, Inc. HBIO |
272 Capital LP | 3,264,796 7.800% |
0 (Unchanged) |
Filing History |
| 2023-02-15 5:37 pm Sale |
2020-12-31 | 13G | inTEST Corporation INTT |
272 Capital LP | 0 0.000% |
-836,918 (Position Closed) |
Filing History |
| 2023-02-15 5:30 pm Purchase |
2022-11-29 | 13G | Harvard Bioscience, Inc. HBIO |
272 Capital LP | 3,264,796 7.840% |
3,264,796 (New Position) |
Filing History |
| 2023-02-15 5:27 pm Purchase |
2022-05-09 | 13G | The Arena Group Holdings, Inc. AREN |
272 Capital LP | 1,654,698 9.070% |
1,654,698 (New Position) |
Filing History |
| 2022-12-05 5:14 pm Purchase |
2022-12-01 | 13D | Sequans Communications S.A. SQNS |
272 Capital LP | 7,948,219 10.400% |
833,280 (+11.71%) |
Filing History |
| 2022-10-18 5:01 pm Purchase |
2022-09-30 | 13D | CAMP4 Therapeutics Corporation CAMP |
272 Capital LP | 135,955 8.440% |
39,035 (+40.28%) |
Filing History |
| 2022-09-06 5:00 pm Purchase |
2022-09-01 | 13D | Sequans Communications S.A. SQNS |
272 Capital LP | 7,114,939 9.300% |
1,349,606 (+23.41%) |
Filing History |
| 2022-07-22 4:15 pm Purchase |
2022-07-12 | 13D | CAMP4 Therapeutics Corporation CAMP |
272 Capital LP | 96,920 6.170% |
38,021 (+64.55%) |
Filing History |
| 2022-06-22 5:00 pm Purchase |
2022-06-21 | 13D | Mercury Systems, Inc. MRCY |
272 Capital LP | 1,375,465 3.810% |
1,375,465 (New Position) |
Filing History |
| 2022-05-26 3:26 pm Purchase |
2022-05-12 | 13D | CAMP4 Therapeutics Corporation CAMP |
272 Capital LP | 58,899 3.760% |
58,899 (New Position) |
Filing History |
| 2022-03-24 12:11 pm Purchase |
2022-03-15 | 13D | Sequans Communications S.A. SQNS |
272 Capital LP | 5,765,333 8.100% |
5,765,333 (New Position) |
Filing History |
| 2021-01-20 11:44 am Purchase |
2020-12-31 | 13G | inTEST Corporation INTT |
272 Capital LP | 836,918 7.900% |
836,918 (New Position) |
Filing History |